Multiple Logistic Regression Model for Determinants of Injectable Contraceptive Uptake Among Women of Reproductive Age in Kenya

Kirui, Ernest Kiplangat; Mung’atu, Joseph; Gichangi, Peter; Onguto, Nicholas Odhiambo; Kamondo, Davis Kiruki

doi:10.18502/jfrh.v15i2.6448

Cited by 2 publications

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Kirui [16] studied the factors associated with the use of injectable contraceptives using multiple logistic regression. Education, marital status, wealth index, place of residence, and number of births were all significant predictors of contraceptive use among reproductive-age Kenyan women.…”

Section: Introductionmentioning

confidence: 99%

Time to use modern contraceptives and associated factors among women of reproductive age in Ethiopia: survival analysis of the 2016 Ethiopian demographic and health survey data

Bekere

Asena

Tesfaw

et al. 2022

Preprint

View full text Add to dashboard Cite

Background: Contraceptive methods are one of the most important health interventions of the twenty-first century, and they are critical in slowing population growth and improving women's and family health. Contraceptive methods are now a global issue in general, and in developing countries in particular. Method: This study sought to identify the factors associated with the timing of the use of modern contraceptive methods among Ethiopian women. The study's data were based on EDHS (2016) obtained from CSA. To identify the risk factors associated with when to use modern contraceptive methods, a parametric survival model with frailty was used and compared using AIC and log-likelihood ratio test. Result: The study found that out of a total of 7,890 women, 6,829 (86.55 percent) of the 7,890 women did not use modern contraceptive methods or were censored, while 1,061 (13.45 percent) used modern contraceptive methods during the follow-up period. The minimum and maximum value of time for women to use modern contraceptive methods was one and thirty years, respectively. During the study period, the overall mean and median uptake time were 23.45 and 22 years, respectively. About 20.69 percent of women between the ages of 25 and 29 have used modern contraceptive methods. It is estimated that 20.52 percent of women aged 20 to 24 have used a modern contraceptive method. The modern contraceptive method was used by 19.83 percent of women aged 30-34 years. Modern contraceptive methods were used by 5.56 percent of women aged 45-49 years. In terms of location, 6.83 percent of women in urban areas used modern contraceptive methods, while 6.62 percent of women in rural areas did. there is a significant relationship between women's age group and the time they use modern contraceptive methods. When all other variables were held constant, the estimated time to modern contraceptive uptake for women aged 35-39 years, 40-44 years, and 45-49 years increased by 21.6 percent, 28.5 percent, and 46.6 percent, respectively, when compared to women aged 15-19 years. In Ethiopia, the majority of women who do not receive medical care are those who live in rural areas, and the findings of this study revealed that residence has a significant impact, with women living in rural areas having a 15.5 percent shorter estimated time to use modern contraceptive methods than women living in urban areas. Table 4 further shows that the wealth index has a significant effect on the time to use modern contraceptive methods. When the effects of other variables were held constant, the relative risk of time to use modern contraceptive methods was reduced by 8.3 percent and 17.3 percent for women in the middle and rich wealth index categories, respectively, compared to women in the poor wealth index categories. The educational level of women had a significant impact on the time it took to use modern contraceptive methods. When other variables in the model were held constant, the estimated time to modern contraceptive uptake increased by 5.5 percent and 5.6 percent for primary, secondary, and higher education women, respectively, when compared to illiterate women.Conclusion: The Weibull regression survival model with Gamma frailty model was an appropriate fit of time to use modern contraceptive methods among the fitted frailty models. In comparison to the non-frailty survival models, the estimated frailty model, which accounts for unobservable regional heterogeneity, was found to be more appropriate for fitting time to use modern contraceptive methods across Ethiopian regions. Furthermore, using the selected frailty model results, the independent variables age, place of residence, wealth index, educational status, and television awareness information were identified as factors associated with the time to use modern contraceptive methods at a 5% level of significance.

show abstract

Section: Introductionmentioning

confidence: 99%

Time to use modern contraceptives and associated factors among women of reproductive age in Ethiopia: survival analysis of the 2016 Ethiopian demographic and health survey data

Bekere

Asena

Tesfaw

et al. 2022

Preprint

View full text Add to dashboard Cite

show abstract

Libido–sexual disorders and abandonment of injectable contraceptives among users of the Ivorian Association for Family Well-Being in Korhogo, Côte d’Ivoire

Essis,

Yeo,

Amalaman

et al. 2023

Front. Glob. Womens Health

View full text Add to dashboard Cite

IntroductionThe recent introduction of modern contraceptive methods in resource-limited countries is confronted with the occurrence of undesirable effects that hinder their use in the long term. This study conducted among the users of the Ivorian Association for Family Well-Being in Korhogo describes the libido–sexual problems associated with the discontinuation of injectable contraceptives in former users. The objective of the study was to identify the factors that led to the abandonment of injectable contraceptives among female users of the Ivorian Association for Family Well-Being in Korhogo between 2018 and 2019.Materials and methodsQualitative data were collected from 15 former users (24–38 years old) of injectable contraceptives duration of 2–3 months. Additional data were collected from five health workers aged 35–60 years. In-depth interviews were conducted to explore the experience with injectable contraceptives and reasons for discontinuation. Following data collection, audio-recorded data were transcribed, translated, and coded using thematic analysis through an inductive approach.ResultsSide effects identified as associated with injectable contraceptives include libido–sexual disorders, unusual bleeding, and weight gain. The most common reason for discontinuation were libido–sexual disorders, which impacted the households’ intimacy and provoked their abandonment or the change of contraceptive methods among injectable contraceptive users.ConclusionAdverse events were dominated by libido–sexual disorders, unusual bleeding, and weight gain leading to the abandonment or change of the contraceptive. These results suggest points of intervention for increasing continuation among users. This intervention should include training of health workers to investigate and manage adverse events related to the use of injectable contraceptives and the improvement of communication between health workers and users on adverse events of injectable contraceptive use.

show abstract

Multiple Logistic Regression Model for Determinants of Injectable Contraceptive Uptake Among Women of Reproductive Age in Kenya

Cited by 2 publications

References 16 publications

Time to use modern contraceptives and associated factors among women of reproductive age in Ethiopia: survival analysis of the 2016 Ethiopian demographic and health survey data

Time to use modern contraceptives and associated factors among women of reproductive age in Ethiopia: survival analysis of the 2016 Ethiopian demographic and health survey data

Libido–sexual disorders and abandonment of injectable contraceptives among users of the Ivorian Association for Family Well-Being in Korhogo, Côte d’Ivoire

Contact Info

Product

Resources

About